NEWS & PRESS RELEASES

Restore Protections for Dialysis Patients Act Reaches 50 Cosponsors, Kidney Care Partners Calls for Additional Congressional Action

WASHINGTON – Kidney Care Partners (KCP) – the nation’s largest non-profit, non-partisan kidney care coalition dedicated to protecting access to care and comprised of more than 30 organizations, including patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers – today thanks the 50 members of the U.S. House of Representatives who have signed…

Read More +
Nephrology News & Issues

CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle

CMS issued a final rule increasing the End-stage Renal Disease Prospective Payment System base rate to dialysis facilities by about 2.7% to $273.82 beginning Jan. 1, 2025, according to an agency press release. The final rate is higher than the 2.2% increase to $273.20 in the proposed rule circulated in July and up from the 2024 base…

Read More +
South Jersey Times

Discount criticism of N.J. library protection bill | Letters

As a healthcare professional, it’s my duty to ensure that dialysis treatment – a life-sustaining procedure over 20,000 New Jerseyans living with kidney failure depend on – is as accessible and seamless as possible. For over 40 years, that job was made easier by a law that provided patients on dialysis with the option to…

Read More +
Inside Drug Pricing

ESRD Pay Rule Cements Oral-Only Drugs In Bundled Payment Despite Stakeholder Opposition

CMS on Friday (Nov. 1) finalized a plan to add oral-only drugs to its End-Stage Renal Disease bundled payment system despite stakeholders’ efforts to delay the policy, including legislation passed by the House Energy & Commerce Committee that would have excluded the drugs from the ESRD bundling for another two years. Click here to see the full…

Read More +

Kidney Care Partners Supports Policies to Expand Home Dialysis and Improve Reimbursement for Phosphate-Lowering Drugs, Remains Concerned CMS Has Not Addressed Barriers to Patient Access to Innovative Treatments

WASHINGTON – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers – issued the following comments in response to the recently released final Calendar Year 2025 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), Payment for Renal Dialysis Services…

Read More +

CATEGORIES

ARCHIVES